190 related articles for article (PubMed ID: 33363209)
1. A Potential Peptide From Soy Cheese Produced Using
Chourasia R; Padhi S; Chiring Phukon L; Abedin MM; Singh SP; Rai AK
Front Mol Biosci; 2020; 7():601753. PubMed ID: 33363209
[TBL] [Abstract][Full Text] [Related]
2. A Multifunctional Peptide From
Padhi S; Sanjukta S; Chourasia R; Labala RK; Singh SP; Rai AK
Front Mol Biosci; 2021; 8():636647. PubMed ID: 33869283
[TBL] [Abstract][Full Text] [Related]
3. Screening of cryptogamic secondary metabolites as putative inhibitors of SARS-CoV-2 main protease and ribosomal binding domain of spike glycoprotein by molecular docking and molecular dynamics approaches.
Prateeksha G; Rana TS; Ashthana AK; Barik SK; Singh BN
J Mol Struct; 2021 Sep; 1240():130506. PubMed ID: 33967344
[TBL] [Abstract][Full Text] [Related]
4. Current Strategies of Antiviral Drug Discovery for COVID-19.
Mei M; Tan X
Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
[TBL] [Abstract][Full Text] [Related]
5. In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library.
Shahhamzehei N; Abdelfatah S; Efferth T
Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337106
[TBL] [Abstract][Full Text] [Related]
6. Production and characterization of bioactive peptides in novel functional soybean chhurpi produced using Lactobacillus delbrueckii WS4.
Chourasia R; Chiring Phukon L; Minhajul Abedin M; Sahoo D; Kumar Rai A
Food Chem; 2022 Sep; 387():132889. PubMed ID: 35430540
[TBL] [Abstract][Full Text] [Related]
7. Discovery and mechanism of action of Thonzonium bromide from an FDA-approved drug library with potent and broad-spectrum inhibitory activity against main proteases of human coronaviruses.
Wang R; Zhai G; Zhu G; Wang M; Gong X; Zhang W; Ge G; Chen H; Chen L
Bioorg Chem; 2023 Jan; 130():106264. PubMed ID: 36395603
[TBL] [Abstract][Full Text] [Related]
8. Identification of nut protein-derived peptides against SARS-CoV-2 spike protein and main protease.
Zhao W; Xu G; Yu Z; Li J; Liu J
Comput Biol Med; 2021 Nov; 138():104937. PubMed ID: 34655899
[TBL] [Abstract][Full Text] [Related]
9. Exploring peptidomes of by-products generated during
Chourasia R; Dabrha G; Abedin MM; Phukon LC; Singh AK; Sahoo D; Singh SP; Rai AK
Food Funct; 2024 Jun; 15(11):5987-5999. PubMed ID: 38742436
[TBL] [Abstract][Full Text] [Related]
10. Identifying the natural compound Catechin from tropical mangrove plants as a potential lead candidate against 3CL
Jha RK; Khan RJ; Parthiban A; Singh E; Jain M; Amera GM; Singh RP; Ramachandran P; Ramachandran R; Sachithanandam V; Muthukumaran J; Singh AK
J Biomol Struct Dyn; 2022; 40(24):13392-13411. PubMed ID: 34644249
[TBL] [Abstract][Full Text] [Related]
11. [Bioactive compounds of Jingfang Granules against SARS-CoV-2 virus proteases 3CL
Shang ZP; Yi Y; Yu R; Fan JJ; Huang YX; Qiao X; Ye M
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):907-919. PubMed ID: 36241233
[TBL] [Abstract][Full Text] [Related]
12. Molecular Docking of Azithromycin, Ritonavir, Lopinavir, Oseltamivir, Ivermectin and Heparin Interacting with Coronavirus Disease 2019 Main and Severe Acute Respiratory Syndrome Coronavirus-2 3C-Like Proteases.
Arouche TDS; Martins AY; Ramalho TC; Júnior RNC; Costa FLP; Filho TSA; Neto AMJC
J Nanosci Nanotechnol; 2021 Apr; 21(4):2075-2089. PubMed ID: 33500022
[TBL] [Abstract][Full Text] [Related]
13. ADMET profile and virtual screening of plant and microbial natural metabolites as SARS-CoV-2 S1 glycoprotein receptor binding domain and main protease inhibitors.
Padhi S; Masi M; Chourasia R; Rajashekar Y; Rai AK; Evidente A
Eur J Pharmacol; 2021 Jan; 890():173648. PubMed ID: 33069672
[TBL] [Abstract][Full Text] [Related]
14. Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme.
Bahadur Gurung A; Ajmal Ali M; Lee J; Abul Farah M; Mashay Al-Anazi K
J King Saud Univ Sci; 2020 Sep; 32(6):2845-2853. PubMed ID: 32837113
[TBL] [Abstract][Full Text] [Related]
15. Optimization Rules for SARS-CoV-2 M
Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the role of fucoidan from brown macroalgae in inhibiting SARS-CoV-2 by targeting its main protease and receptor binding domain: Invitro and insilico approach.
Hans N; Gupta S; Patel AK; Naik S; Malik A
Int J Biol Macromol; 2023 Sep; 248():125950. PubMed ID: 37487999
[TBL] [Abstract][Full Text] [Related]
17. In Silico Screening of Some Active Phytochemicals to Identify Promising Inhibitors Against SARS-CoV-2 Targets.
Alagarsamy V; Solomon VR; Murugesan S; Sundar PS; Muzaffar-Ur-Rehman MD; Chandu A; Aishwarya AD; Narendhar B; Sulthana MT; Ravikumar V
Curr Drug Discov Technol; 2023 Oct; ():. PubMed ID: 37861016
[TBL] [Abstract][Full Text] [Related]
18.
Sharma A; Goyal S; Yadav AK; Kumar P; Gupta L
J Biomol Struct Dyn; 2022 Jan; 40(1):86-100. PubMed ID: 32896226
[TBL] [Abstract][Full Text] [Related]
19. Virtual Screening for SARS-CoV-2 Main Protease Inhibitory Peptides from the Putative Hydrolyzed Peptidome of Rice Bran.
Harnkit N; Khongsonthi T; Masuwan N; Prasartkul P; Noikaew T; Chumnanpuen P
Antibiotics (Basel); 2022 Sep; 11(10):. PubMed ID: 36289976
[TBL] [Abstract][Full Text] [Related]
20. Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.
Farouk AE; Baig MH; Khan MI; Park T; Alotaibi SS; Dong JJ
Saudi J Biol Sci; 2021 Jun; 28(6):3262-3269. PubMed ID: 33654454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
